These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3151850)

  • 1. [Study of the role of fluocinolone acetonide (FA) in prolonging the survival of xenografts by using 3H-FA].
    Zhao XF
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1986 Sep; 2(3):212-4, 237. PubMed ID: 3151850
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of fluocinolone acetonide (FA) in prolonging the survival of skin xenografts--histo-morphological study].
    Zhao XF
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1985 Sep; 1(3):206-8, 239. PubMed ID: 3939856
    [No Abstract]   [Full Text] [Related]  

  • 3. [The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogenic skin graft].
    Zhao XF
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):495-7, 510. PubMed ID: 2620608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogeneic skin grafts.
    Zhao XF; Alexander JW; Schroeder T; Babcock GF
    Transplantation; 1988 Oct; 46(4):490-2. PubMed ID: 3051553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of allogeneic skin survival by in vitro treatment with fluocinolone acetonide: effect of incubation time and length of storage.
    Alexander JW; Craycraft TK
    J Trauma; 1974 Oct; 14(10):836-40. PubMed ID: 4608798
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of formulation on the clinical response to topical fluocinolone acetonide.
    Portnoy B
    Br J Dermatol; 1965 Nov; 77(11):579-81. PubMed ID: 5853252
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of rat skin acid and alkaline phosphatase and beta-glucuronidase activity after topical application of fluocinolone acetonide cream.
    Di Pasquale G; Manning JP
    J Pharm Pharmacol; 1970 Aug; 22(8):642-3. PubMed ID: 4394551
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of fluocinolone acetonide on mouse skin sterol metabolism and two-stage carcinogenesis.
    Fukao K; Tanimoto Y; Kayata Y; Yoshiga K; Takada K; Okuda K
    Carcinogenesis; 1988 Sep; 9(9):1661-4. PubMed ID: 3409469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment.
    Choi Y; Takasugi M; Takemura K; Yoshida Y; Kamiya T; Adachi J; Tsuruta D; Ohtani N
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison.
    Stoughton RB
    Arch Dermatol; 1969 Jun; 99(6):753-6. PubMed ID: 5814595
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period.
    Driot JY; Novack GD; Rittenhouse KD; Milazzo C; Pearson PA
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):269-75. PubMed ID: 15279731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous resorption of corticosteroids. II. Resorption of flucocinolone acetonide through normal rat skin and its influence].
    Brode E
    Arzneimittelforschung; 1968 May; 18(5):580-5. PubMed ID: 4303730
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidermal DNA synthesis under occlusive dressings in the tritium-thymidine autoardiogram].
    Born W
    Z Haut Geschlechtskr; 1969 May; 44(9):305-10. PubMed ID: 5772389
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of long-term acceptance of xenografts in rats induced by short-term administration of FK506.
    Sakamoto K; Nakajima K; Ochiai T; Asano T; Isono K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):527-9. PubMed ID: 2468222
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluocinolone acetonide promotes the proliferation and mineralization of dental pulp cells.
    Liu Z; Jiang T; Wang Y; Wang X
    J Endod; 2013 Feb; 39(2):217-22. PubMed ID: 23321234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On desoxyribonucleic acid synthesis in psoriatic skin under the influence of fluocinolone acetonide].
    Kalkoff KW; Born W
    Hautarzt; 1965 Dec; 16(12):534-9. PubMed ID: 5871097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.